SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE A

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140037612A1
SERIAL NO

13902297

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates, in part, to improved methods of administering α-galactosidase A for the treatment of α-galactosidase A deficiencies including Fabry disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHIRE HUMAN GENETIC THERAPIES INCMASSACHUSETTS MASSACHUSETTS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Heartlein, Michael W Boxborough, US 46 1004
Lamsa, Justin C Westminster, US 3 15
Nguyen, Vinh Chelsea, US 44 456
Shahrokh, Zahra Weston, US 61 1378
Sturk, Lisa Marie Boston, US 3 15
Taylor, Katherine D Arlington, US 3 15

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation